DECREASED SERUM LEVELS OF SOLUBLE DIPEPTIDYL PEPTIDASE IV ARE ASSOCIATED WITH ALL-CAUSE DEATH IN PATIENTS WITH PERIPHERAL ARTERIAL DISEASE

被引：0
|
作者：
Howanietz, M. T. [1 ]
Herz, C. T. [1 ]
Hoebaus, C. [1 ]
Koppensteiner, R. [1 ]
Schernthaner, G. H. [1 ]
机构：
[1] Med Univ Vienna, Med Angiol 2, Vienna, Austria
来源：
ATHEROSCLEROSIS | 2016年 / 252卷
关键词：
D O I：
10.1016/j.atherosclerosis.2016.07.281
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
EAS16-0748
引用
收藏
页码：E16 / E16
页数：1
相关论文
共 50 条
  • [31] High dietary fiber intake is associated with decreased inflammation and all-cause mortality in patients with chronic kidney disease
    Krishnamurthy, Vidya M. Raj
    Wei, Guo
    Baird, Bradley C.
    Murtaugh, Maureen
    Chonchol, Michel B.
    Raphael, Kalani L.
    Greene, Tom
    Beddhu, Srinivasan
    KIDNEY INTERNATIONAL, 2012, 81 (03) : 300 - 306
  • [32] Risk Factors Associated with All-Cause Death Among Dialysis Patients with Diabetes
    Grzywacz, Anna
    Lubas, Arkadiusz
    Smoszna, Jerzy
    Niemczyk, Stanislaw
    MEDICAL SCIENCE MONITOR, 2021, 27
  • [33] Association of peripheral vascular disease and all-cause mortality in patients with rheumatoid arthritis
    Kaminski, Matthew A.
    Shishehbor, Mehdi H.
    Patel, Taral
    Anwaruddin, Saif
    Huang, Julie C.
    Askari, Arman T.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 49 (09) : 375A - 375A
  • [34] ADMA (ASYMMETRIC DIMETHYLARGININE) PREDICTS ALL-CAUSE MORTALITY AND CARDIOVASCULAR EVENTS IN PATIENTS WITH PERIPHERAL ARTERIAL DISEASE: THE GETABI STUDY
    Anderssohn, M.
    Boeger, R. H.
    Endres, H. G.
    Schwedhelm, E.
    Darius, H.
    Atzler, D.
    Lueneburg, N.
    von Stritzky, B.
    Maas, R.
    Thiem, U.
    Benndorf, R. A.
    Diehm, C.
    ATHEROSCLEROSIS SUPPLEMENTS, 2010, 11 (02) : 52 - 53
  • [35] Serum activity of prolyl endopeptidase, but not of dipeptidyl peptidase IV, is decreased by immunotherapy with IFN-α in high-risk melanoma patients
    Van Gool, AR
    Van Ojik, HH
    Kruit, WHJ
    Mulder, PGH
    Fekkes, D
    Bannink, M
    Scharpé, S
    Stoter, G
    Eggermont, AMM
    Maes, M
    Verkerk, R
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2004, 24 (07): : 411 - 415
  • [36] Dipeptidyl Peptidase-4 Inhibitors, Peripheral Arterial Disease, and Lower Extremity Amputation Risk in Diabetic Patients
    Chang, Chun-Chin
    Chen, Yung-Tai
    Hsu, Chien-Yi
    Su, Yu-Wen
    Chiu, Chun-Chih
    Leu, Hsin-Bang
    Huang, Po-Hsun
    Chen, Jaw-Wen
    Lin, Shing-Jong
    AMERICAN JOURNAL OF MEDICINE, 2017, 130 (03): : 348 - 355
  • [37] SERUM LEVELS OF LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A2 IN PATIENTS WITH PERIPHERAL ARTERIAL DISEASE
    Petrkova, J.
    Navratilova, Z.
    Petrek, M.
    Martin, P.
    ATHEROSCLEROSIS, 2015, 241 (01) : E186 - E186
  • [38] Serum fetuin levels are associated with peripheral arterial disease in patients with type 2 diabetes mellitus
    Eleftheriadou, I.
    Grigoropoulou, P.
    Mourouzis, I.
    Liaskos, C.
    Kokkinos, A.
    Perrea, D.
    Makrilakis, K.
    Katsilambros, N.
    Tentolouris, N.
    DIABETOLOGIA, 2014, 57 : S523 - S523
  • [39] Value of adiponectin as predictor of 5-year all-cause mortality in patients with symptomatic peripheral arterial disease: Results from the Linz Peripheral Arterial Disease (LIPAD) study
    Dieplinger, Benjamin
    Haltmayer, Meinhard
    Poelz, Werner
    Mueller, Thomas
    CLINICA CHIMICA ACTA, 2009, 408 (1-2) : 87 - 91
  • [40] Serum thyrotropin levels predict all-cause and circulatory mortality in patients with invasively treated coronary artery disease
    Voelzke, Henry
    Menzel, Dirk
    Henzler, Julia
    Robinson, Daniel
    Motz, Wolfgang
    Rettig, Rainer
    Doerr, Marcus
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2009, 133 (03) : 407 - 410
12345